Our brain proteomic studies (Ojo et al., pers comm) have indicated a distinct TBI mediated neurodegeneration, which shares some overlap with AD pathogenesis in the hTau and PSAPP models, that is not primarily mediated by tau or amyloid pathogenesis in our model. This evidence concerns the gene MAPT and amyloidosis.